3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Endometrial Neoplasms
2
Rectal Neoplasms
1
Overweight
1
Obesity
1
Motor Activity
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Leukemia
1
Infertility
1
Genetic Diseases, Inborn
1
Breast Neoplasms
1
Interventions
Radiotherapy
5
Oxaliplatin
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
Leucovorin
4
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
sintilimab
2
pembrolizumab
2
fludarabine
2
encorafenib
2
aldesleukin
2
Tomography, X-Ray Computed
2
Specimen Handling
2
Pemetrexed
2
Magnetic Resonance Imaging
2
Irinotecan
2
Gemcitabine
2
Folfox protocol
2
Electrocardiography
2
Drug Therapy
2
Dexamethasone
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Capecitabine
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Tablets
×
30 days
×
Clear all
NCT04503694
2026-05-22
REGINA
Jules Bordet Institute
Phase 2
Active not recruiting
72 enrolled